Full description
HeSANDA 1.0.0 To study is a double-blind, randomised, placebo-controlled trial of daily oral melatonin administration from 39 weeks' gestation in nulliparous pregnant women to reduce induction of labour rates. Induction of labour will be the primary endpoint of the study.Notes
External OrganisationsCurtin University; University of Adelaide; Monash University; University of Technology Sydney
Associated Persons
Monique Rose (Contributor); Jane Warland (Contributor); Lesley Kuliukas (Contributor); Miranda Davies-Tuck (Contributor); Emily Callander (Contributor); Kylie Ekin (Contributor); Clare Ladyman (Contributor)
Monique Rose (Contributor); Jane Warland (Contributor); Lesley Kuliukas (Contributor); Miranda Davies-Tuck (Contributor); Emily Callander (Contributor); Kylie Ekin (Contributor); Clare Ladyman (Contributor)
Issued: 2024
Spatial Coverage And Location
text: Australia
Subjects
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- DOI : 10.60854/4RQM-N332
- global : 629e902b-98ff-423f-98d2-fb4d18eb8d9f